DNA Day Celebrations

GenomeWeb
360Dx
Precision Oncology News

GenomeWeb

DNA Day Celebrations

Apr 15, 2011

Love it or hate it, DNA Day is upon us.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

CRISPR Screen Uncovers Genes That Help Cancer Cells Evade Immune System
Pale Melanoma Susceptibility Linked to Albinism-Related Genes
Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test
Centogene Reports 13 Percent Decline in Q2 Revenues
Metabolon Closes $72M in Debt and Equity Funding
Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

The Scan

Stricter Vaccine Standards

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

Few Billion More

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

Another Trial to Ramp Up

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Genome Research Studies on SARS-CoV-2 Super-Spreaders, Pan-Cancer Epigenetics, More

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.

Menu

DNA Day Celebrations

To read the full story....

Breaking News

CRISPR Screen Uncovers Genes That Help Cancer Cells Evade Immune System

Pale Melanoma Susceptibility Linked to Albinism-Related Genes

Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test

Centogene Reports 13 Percent Decline in Q2 Revenues

Metabolon Closes $72M in Debt and Equity Funding

Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

The Scan

Stricter Vaccine Standards

Few Billion More

Another Trial to Ramp Up

Genome Research Studies on SARS-CoV-2 Super-Spreaders, Pan-Cancer Epigenetics, More

Sponsorships